In any case, based on the plasma levels of the IL1β, IL8 and IL6 cytokines and the BALP and RANKL bone-related markers, three clearly different profiles were identified among HD, and MGUS, SMM and MM patients. This evidence concerns the gene TNFSF11 and Huntington disease.